Watch for Changes to Varenicline and Bupropion Labeling

February 2017

You'll hear about labeling changes for varenicline (Chantix) and bupropion for smoking cessation.

That's because new data suggest that these meds do NOT increase mood changes, agitation, nightmares, or other psychiatric side effects in patients quitting smoking.

In fact, these effects may be due to quitting smoking itself.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Look-Alike/Sound-Alike Stay Alert for Unexpected Sources of Look-Alike Med Errors
Practice Ask About Indications When Taking Med Histories
Medication Errors Use Strategies to Prevent IV Infusion of Irrigation Solutions
Monitoring Help Ensure Nurses Draw Blood Levels of Antibiotics on Time
COPD Expect to See New Inhaler Combos for COPD
Nasal Sprays Avoid Confusion With Two New OTC Fluticasone Nasal Sprays
Antipsychotics Help Ensure Prompt Treatment of Agitation
Infectious Diseases Think of Bezlotoxumab as an Add-On Therapy for C. diff Diarrhea
Topicals Properly Handle a Patient's Own Supply of Eucrisa Ointment for Eczema
Smoking Cessation Watch for Changes to Varenicline and Bupropion Labeling
Adverse Events Watch for Patients on Multiple "Serotonergic" Meds

Watch for Changes to Varenicline and Bupropion Labeling

Practical advice for a better career, with unlimited access to CE

Table of Contents